Equetro Capsule, Extended Release
Product Images NDC 30698-419

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Equetro (NDC 30698-419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Validus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Equetro (carbamazepine) Is A Mood Stabilizer Available For Oral Administration As 100 mg, 200 mg, And 300 mg Extended-release Capsules Of Carbamazepine, Usp. Carbamazepine Is A White To Off-white Powder, Practically Insoluble In Water And Soluble In Alcohol And In Acetone. Its Molecular Weight Is 236.27. (Equetro 01)

The Structural Formula For Equetro (carbamazepine) Is A Mood Stabilizer Available For Oral Administration As 100 mg, 200 mg, And 300 mg Extended-release Capsules Of Carbamazepine, Usp. Carbamazepine Is A White To Off-white Powder, Practically Insoluble In Water And Soluble In Alcohol And In Acetone. Its Molecular Weight Is 236.27. (Equetro 01)
Chemical structure of Carbamazepine showing its molecular framework with annotated carbon positions and functional groups.*
FDA Label Image

Principal Display Panelndc 30698-419-12equetrocarbamazepineextended – Releasecapsules100 mg120 Capsulesrx Only (Equetro 02)

Principal Display Panelndc 30698-419-12equetrocarbamazepineextended – Releasecapsules100 mg120 Capsulesrx Only (Equetro 02)
Equetro 100 mg extended-release capsules label by Validus Pharmaceuticals LLC. The label shows the product name, active ingredient carbamazepine, strength 100 mg, dosage form extended-release capsules, and package count of 120 capsules. It includes a caution that the product should not be used with other carbamazepine-containing products and storage instructions.*
FDA Label Image

Principal Display Panelndc 30698-421-12equetrocarbamazepineextended – Releasecapsules200 mg120 Capsulesrx Only (Equetro 03)

Principal Display Panelndc 30698-421-12equetrocarbamazepineextended – Releasecapsules200 mg120 Capsulesrx Only (Equetro 03)
Label for Equetro extended-release capsules containing 200 mg of carbamazepine. The label shows the brand name Equetro, active ingredient carbamazepine, strength 200 mg, and package size of 120 capsules. The manufacturer is Validus Pharmaceuticals LLC. The label includes dosage form as extended-release capsules and marks the product as Rx only.*
FDA Label Image

Principal Display Panelndc 30698-423-12equetrocarbamazepineextended – Releasecapsules300 mg120 Capsulesrx Only (Equetro 04)

Principal Display Panelndc 30698-423-12equetrocarbamazepineextended – Releasecapsules300 mg120 Capsulesrx Only (Equetro 04)
Packaging label for Equetro extended-release capsules containing 300 mg of carbamazepine. The label indicates a package size of 120 capsules for oral use. It includes the Validus Pharmaceuticals LLC logo and instructions that the medication is for prescription use only. The label also cautions against use with other carbamazepine-containing products.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.